← Eichor
Condition: Plasmapheresis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Plasmapheresis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

ALSS - DPMAS and Therapeutic Plasma Exchange (TPE), Its Effect on Primary Coagulation, Inflammation and the Function of
NA · 1 location(s) · Institute for Clinical and Experimental Medicine · NCT07329036Apheresis and Specimen Collection Procedures to Obtain Plasma, Peripheral Blood Mononuclear Cells (PBMCs) and Other Spec
Phase N/A · 3 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00067054Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers
Phase 2 · 1 location(s) · Mayo Clinic · NCT07087860Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)
Phase 3 · 33 location(s) · Mayo Clinic · NCT07100990Therapeutic Plasma Exchange in Septic Shock: A Pilot Study
Phase 2 · 11 location(s) · University of Manitoba · NCT05093075Plasmapheresis in Amyotrophic Lateral Sclerosis With Autoantibody Against NRIP 2 (PALADIN2)
NA · 1 location(s) · National Taiwan University Hospital · NCT07726563The Efficacy and Safety of Desensitation Regimen for Patients With High Titers of Anti-HLA Antibodies Prior to Allo-HSCT
Phase 2 · 1 location(s) · Anhui Provincial Hospital · NCT06362967Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use
Phase N/A · 1 location(s) · National Institutes of Health Clinical Center (CC) · NCT00001846Analysis of TPE Treatments With multiFiltratePRO
Phase N/A · 3 location(s) · Fresenius Medical Care Deutschland GmbH · NCT06272084Treatment of Chronic Active Antibody Mediated Rejection With Tocilizumab
NA · 1 location(s) · Shahid Beheshti University of Medical Sciences · NCT07006532Evaluation for Therapeutic Plasma Exchange for Immune Mediated Neurological Disease
Phase N/A · 1 location(s) · Al-Azhar University · NCT07197099Immunoadsorption Versus Plasma Exchange for Treatment of Guillain-Barré Syndrome (GBS)
Phase N/A · 1 location(s) · University of Ulm · NCT04871035Efficacy of Add-on Plasma Exchange As an Adjunctive Strategy Against Septic Shock
NA · 25 location(s) · Hannover Medical School · NCT05726825Biorepository and Registry for Plasma Exchange Patients
Phase N/A · 1 location(s) · Charles M Knudson · NCT05004493Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder
Phase 3 · 1 location(s) · Tianjin Medical University General Hospital · NCT07420296Immunoadsorption in Autoimmune Long COVID
Phase 2 · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT07316127Efficacy and Safety of Immunosuppression, Caplacizumab and Plasma Infusion Without Therapeutic Plasma Exchange in Immune
NA · 30 location(s) · University Hospital, Rouen · NCT06291025Experience With Therapeutic Plasma Exchange in the Pediatric Nephrology Unit of Sohag University Hospital
Phase N/A · 1 location(s) · Sohag University · NCT07158463Clinical Performance of the New Plasma Filter PX2 in TPE Treatments
NA · 7 location(s) · Fresenius Medical Care Deutschland GmbH · NCT06382675Combination of DPMAS and Low Volume PE for Patients With HBV Related ACLF
Phase N/A · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT04597164Coagulation Disorders Secondary to Two Plasmapheresis Techniques (Double Filtration Plasmapheresis vs. PFS). Descriptive
NA · 1 location(s) · Centre Hospitalier Universitaire de Nīmes · NCT06571552Standard Volume vs. High Volume Plasma Exchange in Pediatric Acute Liver Failure
NA · 1 location(s) · Institute of Liver and Biliary Sciences, India · NCT06831643Efficacy and Safety of Cytokine Adsorption and Plasma Exchange in Patients With ACLF and Sepsis
NA · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT06562803
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.